CAS: 537672-41-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-bromo-N'-butylbenzohydrazide REF: IN-DA00DB9ECAS: 537672-41-6 | 96% | To inquire | Tue 10 Dec 24 |
 | UF010 REF: TM-T3205CAS: 537672-41-6 | 98.03% - 98.11% | 35.00 €~252.00 € | Fri 13 Dec 24 |
 | UF010 REF: 3D-MWA67241CAS: 537672-41-6 | Min. 95% | To inquire | Fri 17 Jan 25 |
4-bromo-N'-butylbenzohydrazide
CAS:537672-41-6
Formula:
C11H15BrN2O
Purity:
96%
Color and Shape:
Solid
Molecular weight:
271.1536
Ref: IN-DA00DB9E
| 1g | To inquire | ||
| 5mg | 81.00 € | ||
| 10mg | 105.00 € | ||
| 25mg | 148.00 € | ||
| 50mg | 236.00 € | ||
| 100mg | 507.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
UF010
CAS:537672-41-6
UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 …
Formula:
C11H15BrN2O
Purity:
98.03% - 98.11%
Color and Shape:
Solid
Molecular weight:
271.15
Ref: TM-T3205
| 10mg | 46.00 € | ||
| 25mg | 78.00 € | ||
| 50mg | 110.00 € | ||
| 100mg | 167.00 € | ||
| 200mg | 252.00 € | ||
| 1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
UF010
CAS:537672-41-6
UF010 is a potential cancer therapy that has been shown to induce dedifferentiation of cancer …
Formula:
C11H15BrN2O
Purity:
Min. 95%
Molecular weight:
271.15 g/mol
Ref: 3D-MWA67241
| 100mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
